FDA inspection
Renalytix AI, Inc.: FDA inspection ending Apr 11, 2025
FDA inspection 1268237 · Voluntary Action Indicated (VAI) · Long Island City, NY
Key facts
| Inspection ID | 1268237 |
|---|---|
| Firm | Renalytix AI, Inc. |
| FEI number | 3018739912 |
| Address | 101 6th Ave Fl 3 Rm 324 |
| City | Long Island City |
| State | NY |
| ZIP | 11101 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Apr 11, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data